Cranberry proanthocyanidins have anti-biofilm properties against pseudomonas aeruginosa

BMC Complementary and Alternative Medicine

Volumn 14, Issue 1, 2014, Pages

  Ulrey, Robert K ^a   Barksdale, Stephanie M ^a   Zhou, Weidong ^a   Van Hoek, Monique L ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

Biofilm; Cranberry; Proanthocyanidins; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CRYSTAL VIOLET; GENTAMICIN; PROANTHOCYANIDIN A TYPE; PROANTHOCYANIDIN DERIVATIVE; RESAZURIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PLANT EXTRACT; PROANTHOCYANIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CELL MOTILITY; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRANBERRY; DRUG POTENTIATION; DRUG SCREENING; GALLERIA MELLONELLA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; ANIMAL; CHEMISTRY; DIET THERAPY; DRUG EFFECTS; FRUIT; METABOLISM; MICROBIOLOGY; MOTH; PATHOGENICITY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; FRUIT; MOTHS; PLANT EXTRACTS; PROANTHOCYANIDINS; PROTEOMICS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VACCINIUM MACROCARPON;

EID: 84924333674     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-499     Document Type: Article

References (50)

1. Flemming HC, Wingender J: The biofilm matrix. Nat Rev Microbiol 2010,8(9):623-633.
2. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999,284(5418):1318-1322. 10.1126/science.284.5418.1318
3. Kuzminski LN: Cranberry juice and urinary tract infections: is there a beneficial relationship? Nutr Rev 1996,54(11 Pt 2):S87-S90.
4. Fleet JC: New support for a folk remedy: cranberry juice reduces bacteriuria and pyuria in elderly women. Nutr Rev 1994,52(5):168-170.
5. Borukh IF, Kirbaba VI, Senchuk GV: [Antimicrobial properties of cranberry]. Vopr Pitan 1972,31(5):82.
6. Foo LY, Lu Y, Howell AB, Vorsa N: A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod 2000,63(9):1225-1228. 10.1021/np000128u
7. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M: A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005,66(18):2281-2291. 10.1016/j.phytochem.2005.05.022
8. Bodet C, Piche M, Chandad F, Grenier D: Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry. J Antimicrob Chemother 2006,57(4):685-690. 10.1093/jac/dkl031
9. Hidalgo G, Ponton A, Fatisson J, O'May C, Asadishad B, Schinner T, Tufenkji N: Induction of a state of iron limitation in uropathogenic Escherichia coli CFT073 by cranberry-derived proanthocyanidins as revealed by microarray analysis. Appl Environ Microbiol 2011,77(4):1532-1535. 10.1128/AEM.02201-10
10. Ahuja S, Kaack B, Roberts J: Loss of fimbrial adhesion with the addition of Vaccinum macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol 1998,159(2):559-562. 10.1016/S0022-5347(01)63983-1
11. Sobota AE: Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984,131(5):1013-1016.
12. Tapiainen T, Jauhiainen H, Jaakola L, Salo J, Sevander J, Ikaheimo I, Pirttila AM, Hohtola A, Uhari M: Biofilm formation and virulence of uropathogenic Escherichia coli in urine after consumption of cranberry-lingonberry juice. Eur J Clin Microbiol Infect Dis 2012,31(5):655-662. 10.1007/s10096-011-1355-2
13. Yamanaka A, Kimizuka R, Kato T, Okuda K: Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 2004,19(3):150-154. 10.1111/j.0902-0055.2004.00130.x
14. Yamanaka A, Kouchi T, Kasai K, Kato T, Ishihara K, Okuda K: Inhibitory effect of cranberry polyphenol on biofilm formation and cysteine proteases of Porphyromonas gingivalis. J Periodontal Res 2007,42(6):589-592. 10.1111/j.1600-0765.2007.00982.x
15. Amer LS, Bishop BM, van Hoek ML: Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Biochem Biophys Res Commun 2010,396(2):246-251. 10.1016/j.bbrc.2010.04.073
16. O'May C, Ciobanu A, Lam H, Tufenkji N: Tannin derived materials can block swarming motility and enhance biofilm formation in Pseudomonas aeruginosa. Biofouling 2012,28(10):1063-1076. 10.1080/08927014.2012.725130
17. Bonifait L, Grenier D: Cranberry polyphenols: potential benefits for dental caries and periodontal disease. J Can Dent Assoc 2010, 76:a130.
18. Duarte S, Gregoire S, Singh AP, Vorsa N, Schaich K, Bowen WH, Koo H: Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett 2006,257(1):50-56. 10.1111/j.1574-6968.2006.00147.x
19. Matsushima M, Suzuki T, Masui A, Kasai K, Kouchi T, Takagi A, Shirai T, Mine T: Growth inhibitory action of cranberry on Helicobacter pylori. J Gastroenterol Hepatol 2008,23(Suppl 2):S175-S180.
20. Yamanaka-Okada A, Sato E, Kouchi T, Kimizuka R, Kato T, Okuda K: Inhibitory effect of cranberry polyphenol on cariogenic bacteria. Bull Tokyo Dent Coll 2008,49(3):107-112. 10.2209/tdcpublication.49.107
21. La VD, Labrecque J, Grenier D: Cytoprotective effect of proanthocyanidin-rich cranberry fraction against bacterial cell wall-mediated toxicity in macrophages and epithelial cells. Phytother Res 2009,23(10):1449-1452. 10.1002/ptr.2799
22. Toivanen M, Ryynanen A, Huttunen S, Duricova J, Riihinen K, Torronen R, Lapinjoki S, Tikkanen-Kaukanen C: Binding of Neisseria meningitidis pili to berry polyphenolic fractions. J Agric Food Chem 2009,57(8):3120-3127. 10.1021/jf803488s
23. Pseudomonas aeruginosa: Infections and Treatment, Volume 12. New York: Informa Health Care; 1994.
24. Ciofu O, Hansen CR, Hoiby N: Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med 2013,19(3):251-258. 10.1097/MCP.0b013e32835f1afc
25. Dean SN, Bishop BM, van Hoek ML: Susceptibility of pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37. Front Microbiol 2011, 2:128.
26. Tremblay J, Deziel E: Improving the reproducibility of Pseudomonas aeruginosa swarming motility assays. J Basic Microbiol 2008,48(6):509-515. 10.1002/jobm.200800030
27. Durham-Colleran MW, Verhoeven AB, van Hoek ML: Francisella novicida forms in vitro biofilms mediated by an orphan response regulator. Microb Ecol 2010,59(3):457-465. 10.1007/s00248-009-9586-9
28. Dean SN, Bishop BM, van Hoek ML: Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 2011, 11:114. 10.1186/1471-2180-11-114
29. O'Toole GA: Microtiter dish biofilm formation assay. J Visual Exp 2011, 47:2437.
30. Ahmad S, Hunter L, Qin A, Mann BJ, van Hoek ML: Azithromycin effectiveness against intracellular infections of Francisella. BMC Microbiol 2010, 10:123. 10.1186/1471-2180-10-123
31. Hall MJ, Middleton RF, Westmacott D: The fractional inhibitory concentration (FIC) index as a measure of synergy. J Antimicrob Chemother 1983,11(5):427-433. 10.1093/jac/11.5.427
32. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, Blais J, Cho D, Chamberland S, Renau T, Leger R, Hecker S, Watkins W, Hoshino K, Ishida H, Lee VJ: Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001,45(1):105-116. 10.1128/AAC.45.1.105-116.2001
33. Tolker-Nielsen T, Sternberg C: Growing and Analyzing Biofilms in Flow Chambers. In Current Protocols in Microbiology. Hoboken, NJ: John Wiley & Sons, Inc; 2005.
34. Zhou W, Capello M, Fredolini C, Racanicchi L, Piemonti L, Liotta LA, Novelli F, Petricoin EF: Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. J Proteome Res 2012,11(2):554-563. 10.1021/pr2009274
35. Elias JE, Gygi SP: Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 2007,4(3):207-214. 10.1038/nmeth1019
36. McKenney ES, Sargent M, Khan H, Uh E, Jackson ER, San Jose G, Couch RD, Dowd CS, van Hoek ML: Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy. PLoS One 2012,7(10):e38167. 10.1371/journal.pone.0038167
37. O'Loughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL: A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc Natl Acad Sci U S A 2013,110(44):17981-17986. 10.1073/pnas.1316981110
38. Wu H, Song Z, Hentzer M, Andersen JB, Molin S, Givskov M, Hoiby N: Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J Antimicrob Chemother 2004,53(6):1054-1061. 10.1093/jac/dkh223
39. Lin B, Johnson BJ, Rubin RA, Malanoski AP, Ligler FS: Iron chelation by cranberry juice and its impact on Escherichia coli growth. BioFactors (Oxford, England) 2011,37(2):121-130. 10.1002/biof.110
40. Andres MT, Viejo-Diaz M, Perez F, Fierro JF: Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2005,49(4):1613-1616. 10.1128/AAC.49.4.1613-1616.2005
41. Woolfrey BF, Lally RT, Ederer MN, Quall CO: Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin. J Clin Microbiol 1984,19(4):502-505.
42. Koo H, Duarte S, Murata RM, Scott-Anne K, Gregoire S, Watson GE, Singh AP, Vorsa N: Influence of cranberry proanthocyanidins on formation of biofilms by Streptococcus mutans on saliva-coated apatitic surface and on dental caries development in vivo. Caries Res 2010,44(2):116-126. 10.1159/000296306
43. Leshem R, Maharshak I, Ben Jacob E, Ofek I, Kremer I: The effect of nondialyzable material (NDM) cranberry extract on formation of contact lens biofilm by Staphylococcus epidermidis. Invest Ophthalmol Vis Sci 2011,52(7):4929-4934. 10.1167/iovs.10-5335
44. Feldman M, Weiss EI, Ofek I, Steinberg D: Interference of cranberry constituents in cell-cell signaling system of Vibrio harveyi. Curr Microbiol 2009,59(4):469-474. 10.1007/s00284-009-9462-3
45. Labrecque J, Bodet C, Chandad F, Grenier D: Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother 2006,58(2):439-443. 10.1093/jac/dkl220
46. Polak D, Naddaf R, Shapira L, Weiss EI, Houri-Haddad Y: Protective potential of non-dialyzable material fraction of cranberry juice on the virulence of P. gingivalis and F. nucleatum mixed infection. J Periodontol 2013,84(7):1019-1025. 10.1902/jop.2012.120331
47. O'May C, Tufenkji N: The swarming motility of Pseudomonas aeruginosa is blocked by cranberry proanthocyanidins and other tannin-containing materials. Appl Environ Microbiol 2011,77(9):3061-3067. 10.1128/AEM.02677-10
48. Foo LY, Lu Y, Howell AB, Vorsa N: The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000,54(2):173-181. 10.1016/S0031-9422(99)00573-7
49. Cai Y, Wang R, An MM, Liang BB: Iron-Depletion prevents biofilm formation in Pseudomonas Aeruginosa through twitching mobility and quorum sensing. Brazilian J Microbiol 2010,41(1):37-41. 10.1590/S1517-83822010000100008
50. Farha MA, Brown ED: Discovery of antibiotic adjuvants. Nat Biotechnol 2013,31(2):120-122. 10.1038/nbt.2500